The Blood and Marrow Transplantation Program at Nicklaus Children's Hospital is South Florida’s first and most experienced care provider for children requiring blood or bone marrow transplantation. The program is one of only two pediatric blood and marrow transplant centers in South Florida and performs more than 30 blood and marrow transplants per year.
Established in 1991, the program was originally accredited in 2003 by the Foundation for the Accreditation of Cellular Therapies (FACT) for all aspects of blood or marrow transplantation (cellular therapy). The program continues to meet the rigorous FACT standards, having achieved its most recent reaccreditation in 2020. FACT accreditation is given to organizations that exceed standards in patient care and laboratory practices.
We treat patients with malignant and nonmalignant disorders, and use both Autologous and Allogeneic donors. It includes peripheral blood, bone marrow and cord blood (single or double), from HLA-matched family members, haplo-identical family members and unrelated donors.
Nicklaus Children's Hospital's Cancer and Blood Disorders Center is one of few in the state to offer the latest immune cell treatment for children and adolescents with certain types of leukemia.
The treatment, known as chimeric antigen receptor T-cell (CAR T) therapy uses a patient's own immune system cells to treat acute lymphoblastic leukemia (ALL) among other types of cancer. The Nicklaus Children's Cancer & Blood Disorders Center is an approved treatment facility to deliver the FDA- approved CAR T-Cell therapy to children and adolescents with certain types of pediatric cancers.
Treatments and Procedures
Malignant conditions treated with Blood and Marrow Transplant
Non-malignant conditions treated with Blood and Marrow Transplant
Excellent Outcomes Close to Home
The Blood and Marrow Transplant Program maintains outcomes that are the best in the region as reported by the National Marrow Donor Program (NMDP). The program’s experience and dedication to quality and in-depth staff training continues to drive outcomes that well exceed predicted outcomes.
Access to the Latest Research Protocols and Data
The Blood and Marrow Transplant Program is a Children’s Oncology Group (COG) accredited center for transplants and is a member of the Pediatric Blood and Marrow Transplant Consortium (PBMTC) and the International Blood and Marrow Transplant Registry (IBMTR). Membership in these organizations brings access to the very latest research protocols and national and international research data.